We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cidara Therapeutics Inc | NASDAQ:CDTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.17 | -1.42% | 11.81 | 11.51 | 11.80 | 11.86 | 11.0161 | 11.85 | 107,666 | 22:00:06 |
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
46-1537286
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
|
|
(858) 752-6170
|
(Address of Principal Executive Offices)
|
|
(Registrant’s Telephone Number, Including Area Code)
|
Large accelerated filer
|
o
|
|
Accelerated filer
|
x
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
|
Emerging growth company
|
x
|
|
||
|
|
|
|
Cidara Therapeutics, Inc.
|
|
|
|
|
Date: December 15, 2017
|
By:
|
/s/ Jeffrey Stein, Ph.D.
|
|
|
Jeffrey Stein, Ph.D.
|
|
|
President and Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
|
Date: December 15, 2017
|
By:
|
/s/ Matthew Onaitis
|
|
|
Matthew Onaitis
|
|
|
Chief Financial Officer and General Counsel
|
|
|
(Principal Financial Officer)
|
1 Year Cidara Therapeutics Chart |
1 Month Cidara Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions